These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33643910)

  • 1. Deep Neural Networks Outperform the CAPRA Score in Predicting Biochemical Recurrence After Prostatectomy.
    Sargos P; Leduc N; Giraud N; Gandaglia G; Roumiguié M; Ploussard G; Rozet F; Soulié M; Mathieu R; Artus PM; Niazi T; Vinh-Hung V; Beauval JB
    Front Oncol; 2020; 10():607923. PubMed ID: 33643910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of biochemical recurrence-free survival after radical prostatectomy by cancer of the prostate risk assessment post-surgical (CAPRA-S) score.
    Aktas BK; Ozden C; Bulut S; Tagci S; Erbay G; Gokkaya CS; Baykam MM; Memis A
    Asian Pac J Cancer Prev; 2015; 16(6):2527-30. PubMed ID: 25824791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of four pre-operative models for prediction of biochemical recurrence after radical prostatectomy in localised prostate cancer.
    Kutluhan MA; Ünal S; Özsoy E; Şahin A; Özayar A; Okulu E; Kayıgil Ö
    Int J Clin Pract; 2021 Oct; 75(10):e14682. PubMed ID: 34331823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel nomogram provides improved accuracy for predicting biochemical recurrence after radical prostatectomy.
    Xia HZ; Bi H; Yan Y; Yang B; Ma RZ; He W; Zhu XH; Zhang ZY; Zhang YT; Ma LL; Hou XF; Wirth GJ; Lu J
    Chin Med J (Engl); 2021 Jun; 134(13):1576-1583. PubMed ID: 34133352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.
    Cooperberg MR; Davicioni E; Crisan A; Jenkins RB; Ghadessi M; Karnes RJ
    Eur Urol; 2015 Feb; 67(2):326-33. PubMed ID: 24998118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate Surface Distension and Tumor Texture Descriptors From Pre-Treatment MRI Are Associated With Biochemical Recurrence Following Radical Prostatectomy: Preliminary Findings.
    Shiradkar R; Ghose S; Mahran A; Li L; Hubbard I; Fu P; Tirumani SH; Ponsky L; Purysko A; Madabhushi A
    Front Oncol; 2022; 12():841801. PubMed ID: 35669420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of biochemical recurrence in pT3b prostate cancer after radical prostatectomy without adjuvant radiotherapy.
    Pagano MJ; Whalen MJ; Paulucci DJ; Reddy BN; Matulay JT; Rothberg M; Scarberry K; Patel T; Shapiro EY; RoyChoudhury A; McKiernan J; Benson MC; Badani KK
    Prostate; 2016 Feb; 76(2):226-34. PubMed ID: 26481325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
    Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
    Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning algorithms can more efficiently predict biochemical recurrence after robot-assisted radical prostatectomy.
    Ekşi M; Evren İ; Akkaş F; Arıkan Y; Özdemir O; Özlü DN; Ayten A; Sahin S; Tuğcu V; Taşçı AI
    Prostate; 2021 Sep; 81(12):913-920. PubMed ID: 34224165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating artificial intelligence in urology: Supervised machine learning algorithms demonstrate comparative advantage over nomograms in predicting biochemical recurrence after prostatectomy.
    Tan YG; Fang AHS; Lim JKS; Khalid F; Chen K; Ho HSS; Yuen JSP; Huang HH; Tay KJ
    Prostate; 2022 Feb; 82(3):298-305. PubMed ID: 34855228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CAPRA&PDE4D5/7/9 Prognostic Model Is Significantly Associated with Adverse Post-Surgical Pathology Outcomes.
    Gulliver C; Huss S; Semjonow A; Baillie GS; Hoffmann R
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Oncological Outcomes After Radical Prostatectomy According to Preoperative and Postoperative Cancer of the Prostate Risk Assessment Scores: Results from a Large, Two-center Experience.
    Leyh-Bannurah SR; Dell'Oglio P; Zaffuto E; Briganti A; Schiffmann J; Pompe RS; Tilki D; Heinzer H; Graefen M; Karakiewicz PI; Budäus L
    Eur Urol Focus; 2019 Jul; 5(4):568-576. PubMed ID: 29129756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy.
    Sandeman K; Eineluoto JT; Pohjonen J; Erickson A; Kilpeläinen TP; Järvinen P; Santti H; Petas A; Matikainen M; Marjasuo S; Kenttämies A; Mirtti T; Rannikko A
    PLoS One; 2020; 15(7):e0235779. PubMed ID: 32645056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface-enhanced Raman spectroscopy before radical prostatectomy predicts biochemical recurrence better than CAPRA-S.
    Pan J; Shao X; Zhu Y; Dong B; Wang Y; Kang X; Chen N; Chen Z; Liu S; Xue W
    Int J Nanomedicine; 2019; 14():431-440. PubMed ID: 30666105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR-based prognostic nomogram for prostate cancer after radical prostatectomy.
    Zhang YD; Wu CJ; Bao ML; Li H; Wang XN; Liu XS; Shi HB
    J Magn Reson Imaging; 2017 Feb; 45(2):586-596. PubMed ID: 27654116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
    Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
    Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre- and post-operative nomograms to predict recurrence-free probability in korean men with clinically localized prostate cancer.
    Kang M; Jeong CW; Choi WS; Park YH; Cho SY; Lee S; Lee SB; Ku JH; Hong SK; Byun SS; Jeong H; Kwak C; Kim HH; Lee E; Lee SE;
    PLoS One; 2014; 9(6):e100053. PubMed ID: 24936784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patients.
    Budäus L; Isbarn H; Tennstedt P; Salomon G; Schlomm T; Steuber T; Haese A; Chun F; Fisch M; Michl U; Heinzer H; Huland H; Graefen M
    BJU Int; 2012 Dec; 110(11):1714-20. PubMed ID: 22520619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
    May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O
    J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy.
    Ross AE; Feng FY; Ghadessi M; Erho N; Crisan A; Buerki C; Sundi D; Mitra AP; Vergara IA; Thompson DJ; Triche TJ; Davicioni E; Bergstralh EJ; Jenkins RB; Karnes RJ; Schaeffer EM
    Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):64-9. PubMed ID: 24145624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.